NCT02748759

Brief Summary

Anterior Cruciate Ligament (ACL) injuries by trauma are a prevalent pathology. In the USA, about 200.000 injuries are estimated per year, half of which implicate a total rupture of the ligament. Data indicates that the number of ACL injuries is increasing in young athletes and presents a common problem, especially people playing agility sports. One of the most widely used methods for the post-surgical mobilization after ACL is the use of Continuous Passive Motion (CPM) devices. These machines are meant to drain residual fluid from the articulation and maintain the mobility of the joint and muscles in the knee. Even though studies show that, an early mobilization after surgery is beneficial to the rehabilitation of the knee joint, recent studies are questioning the efficiency of the CPM when compared with the goal of application. While literature suggests that efficacy of CPM are related with the magnitude of knee flexion and the Range of Motion (ROM) achieved some studies show that the range of motion measured by the CPM is considerably less than the actual ROM. As other therapy that provides an effective mobilization of the knee joint, the Specific Manual Physical Therapy method (Kaltenborn method) takes in account the physiological combination of rotation and gliding of the two joint surfaces. This technique mobilizes the femorotibial joint by controlling the tibial plateau anteroposterior during flexion and posteroanterior during extension of the knee. Therefore, in the past 30 years there are not studies comparing ROM measurements obtained with CPM and manual physical therapy methods. It is hypothesized that the benefits of the early passive mobilization after ACL reconstructive surgery are diminished by the limited efficacy of currently used CPM devices. The aim of our study was to determine the range of motion achieved with the passive mobilization using a CPM device compared with a manual method (Kaltenborn method) and to assess that ROM measurements provided by the CPM correlates the real ROM.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2014

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2014

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2015

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

April 15, 2016

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 22, 2016

Completed
Last Updated

April 22, 2016

Status Verified

April 1, 2016

Enrollment Period

1.5 years

First QC Date

April 15, 2016

Last Update Submit

April 20, 2016

Conditions

Keywords

Continous Passive MotionManual Physical TherapyRange of Motion, ArticularAnterior Cruciate Ligament ReconstructionRehabilitationKaltenborn Manual Therapy

Outcome Measures

Primary Outcomes (3)

  • Knee Range of Motion (ROM) angle

    Maximum knee flexion angle minus the maximum knee extension angle obtained from 15 repetitions of flexo-extension. Measurements were obtained by CPM device and an external goniometer

    Fifteen hours after surgery

  • Knee maximum flexion

    Maximum knee flexion obtained form 15 repetitions of flexo-extensión. Measurements were obtained by CPM device and an external goniometer

    Fifteen hours after surgery

  • Knee maximum extension

    Maximum knee extension obtained form 15 repetitions of flexo-extensión. Measurements were obtained by CPM device and an external goniometer

    Fifteen hours after surgery

Secondary Outcomes (3)

  • Pain

    Fifteen hours after surgery

  • Fluid volumen drained (ml)

    Fifteen hours after surgery

  • Time (seconds)

    Fifteen hours after surgery

Study Arms (2)

EXP 1: Manual mobilization / CPM

ACTIVE COMPARATOR

Patients were subjected to a manual mobilization using the Kaltenborn approach, in which 15 tibiofemoral glides were applied by a physiotherapist. After a pause of 5 minutes, the patient was collocated in a commercially available CPM device (Kinetec Advanced Prima) and received 15 repetitions of flexo-extension.

Device: CPMOther: Manual mobilization

EXP 2: CPM / Manual mobilization

ACTIVE COMPARATOR

Patients were collocated in a commercially available CPM device (Kinetec Advanced Prima) and received 15 repetitions of flexo-extension. After a pause of 5 minutes, patients were subjected to a manual mobilization using the Kaltenborn approach, in which 15 tibiofemoral glides were applied by a physiotherapist.

Device: CPMOther: Manual mobilization

Interventions

CPMDEVICE

15 repetitions of flexo-extensión with a commercially available CPM device (Kinetec Advanced Prima)

EXP 1: Manual mobilization / CPMEXP 2: CPM / Manual mobilization

Manual mobilization using the Kaltenborn approach, in which 15 tibiofemoral glides were applied by a physiotherapist

EXP 1: Manual mobilization / CPMEXP 2: CPM / Manual mobilization

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Rupture of Anterior cruciate ligament
  • Ligamentoplasty with partial meniscectomy when necessary using arthroscopy technique

You may not qualify if:

  • Patients operated after three weeks post-injury because of greater risk of arthrofibrosis
  • Patients who had medical complications during surgery
  • Patients unable to understand the study protocol and those unwilling to give informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Althaia Xarxa Assistencial Universitària de Manresa

Manresa, Barcelona, 08243, Spain

Location

Study Officials

  • Jesús Montesinos, MD

    Althaia Xarxa Assistencial de Manresa

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Medical Doctor

Study Record Dates

First Submitted

April 15, 2016

First Posted

April 22, 2016

Study Start

May 1, 2014

Primary Completion

November 1, 2015

Study Completion

November 1, 2015

Last Updated

April 22, 2016

Record last verified: 2016-04

Locations